Citrine Global Corp. (CTGL)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 09:37AM EDT
| Previous close | 0.0100 |
| Open | 0.0100 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0100 - 0.0100 |
| 52-week range | 0.0050 - 0.0420 |
| Volume | |
| Avg. volume | 672 |
| Market cap | 9.657M |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireCitrine Global Corp. (CTGL) Announces Binding Agreement to Acquire 51% of iBOT Israel Botanicals, a Revenue-Generating Nutritional Supplements’ Company with Fast-Growing Potential
Tel Aviv, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that it has signed a binding agreement to acquire up to 51% of the shares of iBOT Israel Botanicals Ltd. (iBOT) by initially acquiring 19% and an option to obtain an additional 32% of the equity of iBOT. iBOT, a nutritional supplements’ company with innovative botanical solutions, owns a GMP-certified manufacturing facility approved by the Israeli Ministry of Health. iBOT has hundreds of natural
© 2024 Yahoo. All rights reserved.